Evaluation of HLA Genotype as Predictive Biomarkers for Immunological & Clinical Responses Upon Vaccination with PolyPEPI Vaccines
- Highlighting a novel vaccine platform used to develop both off-the-shelf and personalised peptide vaccines
- Evaluating HLA genotype as predictive biomarker for in vitro measured immunogenicity of peptide vaccines
- Showcasing correlation studies for the identification of a candidate predictive biomarker